Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683774 · ClinicalTrials.gov registry record · NA
Insulin and Polycystic Ovary Syndrome
A NA study of PCOS, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT00683774 is a NA study of PCOS that has completed, run by Virginia Commonwealth University. The registered enrollment target is 21 participants, below the 81-participant average among 8 other PCOS trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00683774, a NA study of PCOS, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Increased insulin levels leads to increased secretion of D-chiro inositol(DCI) from the kidneys in women with PCOS, but not in normal women. This leads to a reduction in circulating DCI and insulin stimulated release of DCI-IPG.To determine if decreasing circulating insulin directly by inhibition of islet insulin release with diazoxide in obese women with PCOS 1)decreases the renal clearance of DCI and 2) increases the circulating concentration of DCI.
Conditions Studied
Interventions
- DRUG diazoxide
Study Locations (1)
Virginia
- General Clinical Research Center - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2005-11 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00683774
The ClinicalTrials.gov registry entry for NCT00683774 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 8 other PCOS trials with a reported enrollment target (74% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PCOS appearing as the primary indexed condition, and to 1 intervention - of which diazoxide is the first listed.
NCT00683774 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00683774 about?
NCT00683774 is a clinical study titled "Insulin and Polycystic Ovary Syndrome". Increased insulin levels leads to increased secretion of D-chiro inositol(DCI) from the kidneys in women with PCOS, but not in normal women. This leads to a reduction in circulating DCI and insulin stimulated release of DCI-IPG.To determine if decreasing circulating insulin directly by inhibition of...
What is the current status of trial NCT00683774?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2005-11. Estimated completion is 2008-12.
What conditions does trial NCT00683774 study?
This clinical trial studies the following conditions: PCOS.
What interventions are being tested in trial NCT00683774?
The interventions under investigation include: diazoxide (DRUG).
Who is sponsoring clinical trial NCT00683774?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00683774 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PCOS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
In Vitro Maturation of Human Eggs
RECRUITING · NA
-
Bicalutamide Therapy in Young Women With NAFLD and PCOS
RECRUITING · Phase 1
-
Androgens and NAFLD Longitudinal Cohort Study
RECRUITING
-
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
ACTIVE NOT RECRUITING · Phase 4
-
Transcriptional and Epigenetic Program of PCOS Women
ACTIVE NOT RECRUITING
-
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.